# Health AI and the Stewardship of Trust: A Convergence Q45 Perspective

Publisher: Convergence Q45

Published: 2026-11-07

Canonical: https://mission.convergenceq45.org/news/health-ai-stewardship-trust

As artificial intelligence becomes part of the conversation about health and care, leaders face a deeply human responsibility: deciding how technology can serve people with wisdom, accountability, and compassion.

Recent FDA guidance gives that conversation a practical foundation. The agency issued updated guidance on clinical decision support software in January 2026 and guidance on planned changes to AI enabled medical devices in August 2025. Together, these developments offer a timely starting point for Convergence Q45 readers exploring the intersection of faith, professional calling, innovation, and public service. [1,2]

The January guidance explains how FDA evaluates certain clinical decision support software functions under the statutory criteria that exclude qualifying functions from the medical device definition. It also addresses software functions that remain within the device framework, including functions intended for patients and caregivers. Intended use and the specific function deserve careful attention when evaluating a health technology. [1]

The August guidance addresses predetermined change control plans for AI enabled devices. These plans describe proposed modifications, the methods for developing and validating them, and an assessment of their impact. FDA reviews a plan within a marketing submission, creating a pathway for specified, authorized updates to proceed under that plan. [2]

For the Convergence Q45 audience, the broader leadership lesson is stewardship. This is an editorial application of the FDA developments: technical capability creates an opportunity to practice discernment about purpose, evidence, responsibility, and the people affected by a decision.

A physician may ask how a tool performs in the population receiving care. An entrepreneur may ask how updates will be tested. A community leader may ask whether people can understand and access a service. A ministry leader may help individuals prepare thoughtful questions for their health professionals. Each role contributes a different form of care.

Five questions can guide that work:

1. **Purpose:** What specific task is the technology designed to support?
2. **Evidence:** What evidence supports its use for the people and setting involved?
3. **Equity:** How has performance been examined across relevant groups, and what access barriers deserve attention?
4. **Accountability:** Who reviews concerns, communicates changes, and takes responsibility for follow through?
5. **Human dignity:** How can people understand the service, ask questions, and participate meaningfully in decisions?

These questions provide a useful discussion framework for the 2027 Missional Journey Across America. Conversations with clinicians, entrepreneurs, educators, and community members could explore how responsible innovation supports the everyday work of serving a neighbor.

For readers, one practical step is to select a health AI tool their organization is considering and request a concise evidence brief addressing these five questions. That brief can give leaders and community members a shared foundation for informed discussion.

The promise of innovation becomes tangible through the care surrounding it: the evidence examined, the questions welcomed, and the people remembered. For Convergence Q45, health AI offers another place where calling can become service and knowledge can become care.


## Sources

1. FDA · Clinical Decision Support Software · January 2026: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software

2. FDA · Predetermined Change Control Plans for AI Enabled Devices · August 2025: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence